This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rauprich, P.
Right arrow Articles by Robertson, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rauprich, P.
Right arrow Articles by Robertson, B.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, September 2000, p. 817-822, Vol. 7, No. 5
1071-412X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Influence of Modified Natural or Synthetic Surfactant Preparations on Growth of Bacteria Causing Infections in the Neonatal Period

Petra Rauprich,1 Oliver Möller,1 Gabriele Walter,1 Egbert Herting,1,2,* and Bengt Robertson2

Department of Pediatrics, University of Göttingen, Göttingen, Germany,1 and Division for Experimental Perinatal Pathology, Department of Woman and Child Health, Karolinska Institute, Stockholm, Sweden2

Received 15 December 1999/Returned for modification 16 February 2000/Accepted 5 July 2000

Connatal bacterial pneumonia is common in neonates. Animal studies and initial clinical reports indicate that surfactant dysfunction is involved in the pathophysiology of severe neonatal pneumonia. Since respiratory distress syndrome and connatal pneumonia may be difficult to differentiate in the first hours of life, neonates with respiratory failure due to bacterial infections might receive surfactant. Under such conditions surfactant components might be catabolized by bacteria and promote bacterial growth. We therefore investigated the influence of three modified natural (Curosurf, Alveofact, and Survanta) and two synthetic (Exosurf and Pumactant) surfactant preparations on the growth of bacteria frequently cultured from blood or tracheal aspirate fluid in the first days of life. Group B streptococci (GBS), Staphyloccocus aureus, and Escherichia coli were incubated in a nutrient-free medium (normal saline) for 5 h at 37°C, together with different surfactants at concentrations of 0, 1, 10, and 20 mg/ml. With the exception of E. coli, incubation in saline alone led to a variable decrease in CFU. In the presence of Alveofact, Exosurf, and Pumactant the decline in bacterial numbers was less marked than in saline alone. Curosurf was bactericidal in a dose-dependent fashion for GBS and had a strong negative impact on the growth of a GBS subtype that lacked the polysaccharide capsule. In contrast, Survanta (10 and 20 mg/ml) significantly promoted the growth of E. coli, indicating that surfactant components may actually serve as nutrients. We conclude that bacterial growth in different surfactant preparations is influenced by microbial species and the composition and dose of the surfactant. Further studies are necessary to elucidate the mechanisms behind our findings and to evaluate the effects of surfactant on bacterial growth in vivo.

* Corresponding author. Mailing address: Department of Pediatrics, University of Göttingen, Robert-Koch Str. 40, D-37075 Göttingen, Germany. Phone: 49-551-396210/396222. Fax: 49-551-396231. E-mail: eherting{at}med.uni-goettingen.de.

Clinical and Diagnostic Laboratory Immunology, September 2000, p. 817-822, Vol. 7, No. 5
1071-412X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Rudiger, M., Tolle, A., Meier, W., Rustow, B. (2005). Naturally derived commercial surfactants differ in composition of surfactant lipids and in surface viscosity. Am. J. Physiol. Lung Cell. Mol. Physiol. 288: L379-L383 [Abstract] [Full Text]  
  • Julkowska, D., Obuchowski, M., Holland, I. B., Seror, Simone. J. (2005). Comparative Analysis of the Development of Swarming Communities of Bacillus subtilis 168 and a Natural Wild Type: Critical Effects of Surfactin and the Composition of the Medium. J. Bacteriol. 187: 65-76 [Abstract] [Full Text]  
  • Wang, Y., Walter, G., Herting, E., Agerberth, B., Johansson, J. (2004). Antibacterial Activities of the Cathelicidins Prophenin (Residues 62 to 79) and LL-37 in the Presence of a Lung Surfactant Preparation. Antimicrob. Agents Chemother. 48: 2097-2100 [Abstract] [Full Text]  
  • van Kaam, A. H., Lachmann, R. A., Herting, E., De Jaegere, A., van Iwaarden, F., Noorduyn, L. A., Kok, J. H., Haitsma, J. J., Lachmann, B. (2004). Reducing Atelectasis Attenuates Bacterial Growth and Translocation in Experimental Pneumonia. Am. J. Respir. Crit. Care Med. 169: 1046-1053 [Abstract] [Full Text]  
  • Clark, H, Reid, K (2003). The potential of recombinant surfactant protein D therapy to reduce inflammation in neonatal chronic lung disease, cystic fibrosis, and emphysema. Arch. Dis. Child. 88: 981-984 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»